Hybrid cardiac imaging / Stephan G. Nekolla, Christoph Rischpler, editors.
This clinically oriented book provides an up-to-date review on the various hybrid imaging modalities that may be employed for the purpose of cardiac imaging. After discussion of generic aspects of hybrid imaging, SPECT/CT, PET/CT, and PET/MRI are each considered in depth. In addition, information is...
Saved in:
Online Access: |
Full Text (via Springer) |
---|---|
Other Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Cham :
Springer,
[2022]
|
Subjects: |
Table of Contents:
- Intro
- Preface
- Contents
- Part I: Generic Aspects of Hybrid Imaging
- 1: Hybrid Imaging and Healthcare Economics
- 1.1 Hybrid Imaging in Stable CAD (SCAD): CTCA and MPI
- 1.2 Health-Economic Implications
- 1.3 Hybrid PET-MRI and Health-Economics Implications
- References
- 2: Industry Perspective on Hybrid Cardiac Imaging
- 2.1 Introduction
- 2.2 Ultra-Fast Cardiac Cameras Based on CZT Technology
- 2.3 Pinhole Imaging
- 2.4 Hybrid Imaging for Dedicated Cardiac SPECT Cameras
- References
- 3: Global and Regional Peculiarities: The IAEA Perspective
- 3.1 Introduction.
- 3.2 Health Expenditures
- 3.3 The Challenge of Introducing Newer Technologies
- 3.4 Diagnostic Efficacy and Cost Effectiveness
- 3.5 Economic Evidence on the Use of Nuclear Cardiology
- 3.6 The Program in Human Health of the IAEA to Support Nuclear Medicine and Hybrid Imaging
- 3.7 Human Resources Capacity Building
- 3.8 The Growth of Hybrid Imaging in Developing World
- 3.9 Assessment of the Utilization of Hybrid Imaging Worldwide
- References
- Part II: SPECT/CT
- 4: Perfusion, Calcium Scoring, and CTA
- 4.1 Coronary Dominancy and Variations.
- 4.2 Calcium Scoring and Assessment of Plaque and Stenosis
- 4.3 Myocardial CT Perfusion by Dynamic CTA
- 4.4 Hybrid Analysis and Image Fusion (SPECT or PET and CTA)
- 4.5 Future Direction and Visions
- References
- 5: Hybrid Imaging of the Autonomic Cardiac Nervous System
- 5.1 Introduction
- 5.2 Cardiac Sympathetic Nervous System Imaging
- 5.3 SPECT and PET Tracers
- 5.3.1 Presynaptic
- 5.3.2 Post-synaptic
- 5.4 Principles in Analysis, Quantification, and Software
- 5.5 Clinical Applications.
- 5.5.1 ANS and Myocardial Ischemia and Infarction and Heart Failure (CMP)/Heart Transplantation
- 5.5.2 Long QT, Brugada, ARVD Detection
- 5.5.3 Predicting Ventricular Arrhythmias and Sudden Cardiac Death with ANS Imaging
- 5.5.4 ANS and Cardiac Resynchronization
- 5.5.5 ANS and Cardiac Amyloidosis
- 5.5.6 ANS and DM
- 5.6 Conclusion and Future Perspectives
- 5.6.1 Potential Novel Tracers
- 5.6.2 Role of PET/MR
- 5.6.3 New Clinical Trial
- 5.6.4 Clinical Implementation
- 5.7 Conclusion
- References
- 6: Dyssynchrony.
- 6.1 Assessment of Left Ventricular Dyssynchrony by SPECT
- 6.2 Dyssynchrony as a Guide for Cardiac Resynchronization Therapy
- 6.3 Dyssynchrony as a Guide for Implantable Cardioverter Defibrillator
- 6.4 Value of Dyssynchrony in Ischemic Heart Disease
- 6.5 Technical Considerations in the Assessment of Dyssynchrony by SPECT
- References
- 7: Novel Techniques: Solid-State Detectors, Dose Reduction (SPECT/CT)
- 7.1 Introduction
- 7.2 Technology
- 7.2.1 Solid-State Detectors
- 7.3 Dedicated Cardiac Systems
- 7.3.1 Detectors
- 7.3.2 Dedicated Cardiac Collimators and Geometries.